Insider Buying: Vita Life Sciences (ASX:VLS) Insider Purchases A$318,500.00 in Stock

Vita Life Sciences Limited (ASX:VLS) insider Henry Townsing acquired 130,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average cost of A$2.45 per share, for a total transaction of A$318,500.00.

Vita Life Sciences Stock Performance

The company has a quick ratio of 1.57, a current ratio of 2.96 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $107.10 million, a price-to-earnings ratio of 11.27 and a beta of 0.46.

Vita Life Sciences Company Profile

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health.